Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BI-1607 + KEYTRUDA & Ipilimumab Details Cancer, Melanoma | Phase 2 Initiation | |
BI-1808 +/- KEYTRUDA Details Advanced malignancies, Cancer | Phase 2a Update | |
BI-1206 Details Cancer, Solid tumor/s | Phase 1/2 Data readout | |
BI-1910 + KEYTRUDA Details Solid tumor/s, Cancer | Phase 1/2 Update | |
BI-1607 Details Solid tumor/s, Cancer | Phase 1 Data readout | |
BT-001 + KEYTRUDA Details Solid tumor/s, Cancer | Phase 1 Data readout |